No Data
No Data
RBC Capital Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $65
9 Health Care Stocks With Whale Alerts In Today's Session
RBC Capital Reiterates Outperform on PTC Therapeutics, Maintains $65 Price Target
PTC Therapeutics Insiders Sold US$2.9m Of Shares Suggesting Hesitancy
BofA Securities Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Maintains Target Price $55
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results